Aminoglycoside formulation for aerosolization
US5508269A · kind A · utility
120Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 1994 |
| Grant date | Apr 16, 1996 |
| Priority date | — |
| Expiry date | Oct 19, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aminoglycoside formulation for delivery by aerosolization. The concentrated aminoglycoside formulation containing an efficacious amount of aminoglycoside able to inhibit 95-100% of susceptible bacteria. Aminoglycoside formulated in 5 ml solution of a quarter normal saline having pH between 5.5 and 6.5. The method for treatment of endobronchial infections by a produced by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5 .mu., produced by a jet or ultrasonic nebulizer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.